Real-world study of new migraine prevention and treatment drugs

This is an observational study that tracks how newer migraine medications—including monoclonal antibodies, gepants, ditans, and sumatriptan-naproxen—work in everyday clinical practice. Instead of testing these medications in a strict laboratory setting, researchers want to understand how well they actually prevent migraine attacks and how tolerable they are when people use them in real life.

Clinical trials test medications under very controlled conditions with carefully selected patients, which doesn't always reflect what happens in everyday medical practice. This study exists to fill that gap by collecting real-world information about how effective and safe these newer migraine treatments are for people like you who are actually using them in regular doctor's offices and clinics.